- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
Patent holdings for IPC class A61K 39/395
Total number of patents in this class: 47102
10-year publication summary
|
3064
|
3469
|
3403
|
3563
|
3850
|
3635
|
3320
|
3016
|
2828
|
1991
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4119 |
879 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
825 |
| Novartis AG | 10175 |
549 |
| Amgen Inc. | 4436 |
527 |
| F. Hoffmann-La Roche AG | 7800 |
497 |
| Janssen Biotech, Inc. | 1785 |
459 |
| The Regents of the University of California | 20842 |
456 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
446 |
| Bristol-myers Squibb Company | 4764 |
380 |
| Hoffmann-La Roche Inc. | 3825 |
337 |
| The Board of Trustees of the Leland Stanford Junior University | 6697 |
290 |
| Memorial Sloan-Kettering Cancer Center | 2056 |
288 |
| Dana-Farber Cancer Institute, Inc. | 2669 |
266 |
| Board of Regents, The University of Texas System | 6149 |
258 |
| The Johns Hopkins University | 5922 |
239 |
| Daiichi Sankyo Company, Limited | 1891 |
230 |
| Eli Lilly and Company | 4114 |
220 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3327 |
213 |
| The Trustees of the University of Pennsylvania | 4432 |
201 |
| Merck Sharp & Dohme LLC | 3738 |
200 |
| Other owners | 39342 |